Examination of ELISA against PCR for assessing treatment efficacy against Cryptosporidium in a clinical trial context.

<h4>Background</h4>Cryptosporidium is a gastrointestinal pathogen that presents a serious opportunistic infection in immunocompromised individuals including those living with human immunodeficiency syndrome. The CRYPTOFAZ trial, previously published, was conducted in Malawi to evaluate t...

Full description

Bibliographic Details
Published in:PLoS ONE
Main Authors: James T Nyirenda, Marc Y R Henrion, Vita Nyasulu, Mike Msakwiza, Wilfred Nedi, Herbert Thole, Jacob Phulusa, Neema Toto, Khuzwayo C Jere, Alex Winter, Leigh A Sawyer, Thomas Conrad, Donnie Hebert, Crystal Chen, Wesley C Van Voorhis, Eric R Houpt, Pui-Ying Iroh Tam, Darwin J Operario
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Online Access:https://doi.org/10.1371/journal.pone.0289929